Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
ProductsRapid PE

Vendor source

Reviewed 11 May 2026

Completeness Strong (72%)

Rapid PE

RapidAI

Rapid PE detects central pulmonary embolism on CTPA studies to alert radiologists and care team members of patients who may be considered for treatment. It can be combined togehter with the mobile application and Rapid RV/LV.

No papers to support — we monitor for new evidence.

Key features

Pulmonary embolism detection

RV/LV ratio

General Information

Product name

Rapid PE

Company

Modality

CT

Main task

Detection

Subspeciality

Chest

Disease targeted

Pulmonary embolism

Regulatory Information

CE Certification

Pathway:

MDR

Class:

Class IIb

Not verified by Health AI Register

FDA Certification

Pathway:

510(k) cleared

Class:

Class II

FDA Number:

K220499

View FDA record

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

Technical Specifications

Patient population age

Adult

Input

CTPA, single energy scans

Input format

DICOM

Output

DICOM Secondary Capture, email, worklist prioritization, mobile notifications

Output format

DICOM, HL7

Integration

Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, docker)

Trigger for analysis

Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload

Processing time

1 - 10 minutes

Population

Not specified

Market Presence

On market since

05-2022

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Number of installations

Source: Vendor | First published: Jul 29, 2025 | Last updated: May 11, 2026